CSL Limited Appoints GSK Executive Deborah Waterhouse as Future CEO
Australian biotechnology firm CSL Limited (CSLLY) has announced that Deborah Waterhouse will succeed as its Chief Executive Officer, effective February 1, 2027. Waterhouse currently serves as the CEO of ViiV Healthcare, a subsidiary of GSK. The appointment follows an extensive months-long executive search conducted by the Melbourne-based company. This leadership transition is aimed at securing long-term strategic direction for CSL's global operations.
Topics: CEO appointment Leadership change